Jennifer Martin, MA (Oxon), FRACP, PhD, is the Chair of Clinical Pharmacology at the University of Newcastle and a general physician in Hunter New England Health. She leads a clinical-academic team of 25 clinicians and researchers that is focused on analysing the clinical and cost-effective use of both novel and existing therapeutics, using rigorous assessment of current data, prediction of clinical efficacy and safety in groups under-represented in clinical trials, and supported by pharmaco-epidemiological data and measurement of surrogates for drug exposure. Ensuring that therapeutics are used in ways appropriate for an individual's pharmacology is also a key part of both the new MD curriculum at the University of Newcastle and in the training of graduates and physician trainees. The Newcastle pharmacology team has collaborations with cancer, palliative care and infectious diseases teams around Australia and New Zealand, and policy roles with statewide, national and international regulatory and reimbursement committees, the College of Physicians and Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists. Assessment of therapeutic claims, clinical trial design and relevance to patient care, and implications of governmental funding decisions are key skill-sets that will be provided to the Editorial Advisory Committee, on which she is delighted to serve.